⌘K

Login Start Free

Home/Filings/4/0001144204-13-031362

4//SEC Filing

Nguyen Binh 4

Accession 0001144204-13-031362

CIK 0001235007other

View on SEC.gov Company Profile

Filed

May 22, 8:00 PM ET

Accepted

May 23, 4:47 PM ET

Size

6.8 KB

Accession

0001144204-13-031362

Insider Transaction Report

Form 4

Period: 2013-05-22

ENDOCYTE INCECYT

VP of Clinical Affairs

Transactions

Exercise/Conversion
Common Stock
2013-05-22$3.55/sh+2,700$9,585→ 2,700 total
Exercise/Conversion
Stock Option (right to buy)
2013-05-22−2,700→ 60,000 total
Exercise: $3.55Exp: 2022-02-28→ Common Stock (2,700 underlying)

Footnotes (1)

[F1]This option is fully vested and immediately exercisable.

Documents

1 file

4
v346122_form4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ENDOCYTE INC

CIK 0001235007

Entity typeother

Related Parties

1

filerCIK 0001523662

Filing Metadata

Form type: 4
Filed: May 22, 8:00 PM ET
Accepted: May 23, 4:47 PM ET
Size: 6.8 KB

View on SEC.gov